Literature DB >> 28410662

Lewy Body Disorders.

Douglas Galasko1.   

Abstract

Dementia syndromes associated with Lewy bodies are subdivided into dementia with Lewy bodies (DLB), an underdiagnosed cause of dementia in the elderly, and Parkinson disease with dementia (PDD), cognitive impairment appearing in people diagnosed with Parkinson disease. Their neuropathologic substrates are the widespread distribution of aggregates of the protein α-synuclein in neurons in cortical brain regions, accompanied by variable Alzheimer pathology. Clinical features of DLB and PDD include distinctive changes in cognition, behavior, movement, sleep, and autonomic function. Diagnostic criteria for DLB and PDD incorporate these features. Current treatment options for DLB and PDD are symptomatic.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; Diagnosis; Lewy body; Management; α-synuclein

Mesh:

Substances:

Year:  2017        PMID: 28410662      PMCID: PMC5912679          DOI: 10.1016/j.ncl.2017.01.004

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  56 in total

Review 1.  Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis.

Authors:  Emily Bomasang-Layno; Iris Fadlon; Andrea N Murray; Seth Himelhoch
Journal:  Parkinsonism Relat Disord       Date:  2015-05-16       Impact factor: 4.891

2.  Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.

Authors:  Zuzana Nedelska; Tanis J Ferman; Bradley F Boeve; Scott A Przybelski; Timothy G Lesnick; Melissa E Murray; Jeffrey L Gunter; Matthew L Senjem; Prashanti Vemuri; Glenn E Smith; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

3.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Authors:  Lon S Schneider; Karen Dagerman; Philip S Insel
Journal:  Am J Geriatr Psychiatry       Date:  2006-03       Impact factor: 4.105

4.  The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia.

Authors:  M P Walker; G A Ayre; J L Cummings; K Wesnes; I G McKeith; J T O'Brien; C G Ballard
Journal:  Br J Psychiatry       Date:  2000-09       Impact factor: 9.319

Review 5.  Dementia associated with Parkinson's disease.

Authors:  Murat Emre
Journal:  Lancet Neurol       Date:  2003-04       Impact factor: 44.182

Review 6.  REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies.

Authors:  Bradley F Boeve; Michael H Silber; Tanis J Ferman
Journal:  J Geriatr Psychiatry Neurol       Date:  2004-09       Impact factor: 2.680

7.  APOE ε4 increases risk for dementia in pure synucleinopathies.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

8.  Risk factors for dementia with Lewy bodies: a case-control study.

Authors:  Brendon P Boot; Carolyn F Orr; J Eric Ahlskog; Tanis J Ferman; Rosebud Roberts; Vernon S Pankratz; Dennis W Dickson; Joseph Parisi; Jeremiah A Aakre; Yonas E Geda; David S Knopman; Ronald C Petersen; Bradley F Boeve
Journal:  Neurology       Date:  2013-07-26       Impact factor: 9.910

9.  Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies.

Authors:  Marco Onofrj; Sara Varanese; Laura Bonanni; John-Paul Taylor; Angelo Antonini; Enza Maria Valente; Simona Petrucci; Fabrizio Stocchi; Astrid Thomas; Bernardo Perfetti
Journal:  J Neurol       Date:  2013-02-12       Impact factor: 4.849

10.  Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Authors:  Jose Bras; Rita Guerreiro; Lee Darwent; Laura Parkkinen; Olaf Ansorge; Valentina Escott-Price; Dena G Hernandez; Michael A Nalls; Lorraine N Clark; Lawrence S Honig; Karen Marder; Wiesje M Van Der Flier; Afina Lemstra; Philip Scheltens; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Sara Ortega-Cubero; Pau Pastor; Tanis J Ferman; Neill R Graff-Radford; Owen A Ross; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Walter Maetzler; Daniela Berg; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Yaroslau Compta; Tamas Revesz; Andrew Lees; Nigel Cairns; Glenda M Halliday; David Mann; Stuart Pickering-Brown; Dennis W Dickson; Andrew Singleton; John Hardy
Journal:  Hum Mol Genet       Date:  2014-06-27       Impact factor: 6.150

View more
  16 in total

Review 1.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 2.  The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

3.  Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.

Authors:  Ching-Chi Chang; Hsin-Hua Li; Yen-Ting Chang; Ying-Jui Ho; Ling-Jia Hsieh; Pai-Yi Chiu; Yu-Shih Cheng; Chih-Li Lin; Te-Jen Lai
Journal:  CNS Neurosci Ther       Date:  2017-11-01       Impact factor: 5.243

Review 4.  Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.

Authors:  Costanza Papagno; Luigi Trojano
Journal:  Neurol Sci       Date:  2017-10-17       Impact factor: 3.307

5.  Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer's Coordinating Center.

Authors:  Sarah Payne; Jane B Shofer; Andrew Shutes-David; Ge Li; Adrienne Jankowski; Pamela Dean; Debby Tsuang
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

6.  The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.

Authors:  Han Soo Yoo; Seok Jong Chung; Soo-Jong Kim; Jung Su Oh; Jae Seung Kim; Byoung Seok Ye; Young Ho Sohn; Phil Hyu Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-04       Impact factor: 9.236

Review 7.  Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.

Authors:  Rotem Iris Orad; Tamara Shiner
Journal:  J Neurol       Date:  2021-01-29       Impact factor: 4.849

8.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

9.  Basic Fibroblast Growth Factor 2-Induced Proteome Changes Endorse Lewy Body Pathology in Hippocampal Neurons.

Authors:  Rohit Kumar; Sainitin Donakonda; Stephan A Müller; Stefan F Lichtenthaler; Kai Bötzel; Günter U Höglinger; Thomas Koeglsperger
Journal:  iScience       Date:  2020-07-09

10.  Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study.

Authors:  Brit Mollenhauer; Frederick DuBois Bowman; Daniel Drake; Jimmy Duong; Kaj Blennow; Omar El-Agnaf; Leslie M Shaw; Jennifer Masucci; Peggy Taylor; Robert M Umek; Jill M Dunty; Chris L Smith; Erik Stoops; Hugo Vanderstichele; Adrian W Schmid; Marc Moniatte; Jing Zhang; Niels Kruse; Hilal A Lashuel; Charlotte Teunissen; Tanja Schubert; Kuldip D Dave; Samantha J Hutten; Henrik Zetterberg
Journal:  J Neurochem       Date:  2018-11-13       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.